VCAM
CVS icon

Van Cleef Asset Management’s CVS Health CVS Stock Holding History

Van Cleef Asset Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-9,504
Closed -$427K – 117
2024
Q4 		$427K Sell
9,504
-7,973
-46% -$447K 0.05% 89
2024
Q3 		$1.1M Sell
17,477
-739
-4% -$43.1K 0.12% 59
2024
Q2 		$1.08M Sell
18,216
-3,880
-18% -$243K 0.13% 56
2024
Q1 		$1.76M Sell
22,096
-6,900
-24% -$527K 0.22% 49
2023
Q4 		$2.29M Sell
28,996
-81,364
-74% -$5.79M 0.32% 44
2023
Q3 		$7.71M Sell
110,360
-70,971
-39% -$5.03M 1.21% 22
2023
Q2 		$12.5M Sell
181,331
-5,416
-3% -$385K 1.93% 14
2023
Q1 		$13.9M Sell
186,747
-1,943
-1% -$163K 2.17% 12
2022
Q4 		$17.6M Sell
188,690
-647
-0.3% -$62.4K 2.9% 6
2022
Q3 		$18.1M Sell
189,337
-97
-0.1% -$9.6K 3.49% 5
2022
Q2 		$17.6M Buy
189,434
+2,974
+2% +$290K 2.97% 8
2022
Q1 		$18.9M Buy
186,460
+115
+0.1% +$12.1K 2.72% 10
2021
Q4 		$19.2M Buy
186,345
+2,681
+1% +$248K 2.7% 10
2021
Q3 		$15.6M Buy
183,664
+3,792
+2% +$318K 2.35% 11
2021
Q2 		$15M Sell
179,872
-2,404
-1% -$197K 2.22% 11
2021
Q1 		$13.7M Buy
182,276
+4,392
+2% +$320K 2.15% 13
2020
Q4 		$12.1M Buy
177,884
+1,311
+0.7% +$85.3K 1.99% 14
2020
Q3 		$10.3M Sell
176,573
-807
-0.5% -$50.2K 1.93% 14
2020
Q2 		$11.5M Buy
177,380
+509
+0.3% +$32.1K 2.34% 10
2020
Q1 		$10.5M Buy
176,871
+83,175
+89% +$5.55M 2.58% 10
2019
Q4 		$6.96M Sell
93,696
-65
-0.1% -$4.56K 1.42% 21
2019
Q3 		$5.91M Buy
+93,761
New +$5.56M 1.3% 24
2016
Q1 		– Sell
-4,200
Closed -$411K – 98
2015
Q4 		$411K Buy
4,200
+250
+6% +$24.5K 0.15% 71
2015
Q3 		$381K Hold
3,950
– – 0.15% 70
2015
Q2 		$414K Hold
3,950
– – 0.15% 75
2015
Q1 		$408K Hold
3,950
– – 0.15% 74
2014
Q4 		$380K Buy
+3,950
New +$348K 0.14% 79

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Van Cleef Asset Management's CVS Position: Q1 2025 in Review

Van Cleef Asset Management sold out of CVS Health (CVS) in Q1 2025, closing a stake of 9,504 shares — an estimated $427K sold.

Van Cleef Asset Management first reported a position in CVS in Q4 2014 and held it in 27 quarters. The position peaked at $19.2M in Q4 2021. 1,752 funds tracked by Wall St. Rank hold CVS as of Q1 2025.

  • Van Cleef Asset Management reported no remaining CVS Health position as of Q1 2025 after selling out during the quarter.
  • Van Cleef Asset Management sold 9,504 CVS Health shares in Q1 2025, an estimated $427K.
  • Van Cleef Asset Management first reported a position in CVS Health in Q4 2014 and held it in 27 quarters.
  • Van Cleef Asset Management's CVS Health position peaked at $19.2M in Q4 2021.
  • 1,752 funds tracked by Wall St. Rank held CVS Health as of Q1 2025.

Based on Van Cleef Asset Management's 13F filing for Q1 2025, filed 30 Apr 2025.